ALBANY, N.Y., Nov. 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq: ANGO ), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company will present at the following investor conferences in November:
- On Wednesday, November 19, 2014, at 1:50 p.m. ET, Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to present at the Stifel 2014 Healthcare Conference in New York City.
- On Thursday, November 20, 2014, at 2 p.m. ET, Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to participate in a Q&A session at the Canaccord Genuity 2014 Medical Technology & Diagnostics Forum in New York City.
A live audio and/or webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm . The replay will be available for 90 days after the event.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com .
Trademarks
AngioDynamics and the AngioDynamics are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact: AngioDynamics, Inc. Mark Frost, CFO (800) 772-6446 x1981 Investor Relations Contacts: EVC Group, Inc. Michael Polyviou/Robert Jones (212) 850-6020; (646) 201-5447 ; Media Contact: EVC Group, Inc. Dave Schemelia (646) 201-5431